Planispine A
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 1202761-42-9
- 分子式: C25H30O6
- 分子量:426.50
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HeLa | IC50 |
21.38 μM
|
Antiproliferative activity against human HeLa cancer cells assessed as reduction in cell viability using CellTiter 96 AQueous One Solution assay with 16 h pre-incubation of planispine A.
Antiproliferative activity against human HeLa cancer cells assessed as reduction in cell viability using CellTiter 96 AQueous One Solution assay with 16 h pre-incubation of planispine A.
|
36364114 |
| HeLa | IC50 |
3.9 μM
|
Antiproliferative activity against human HeLa cancer cells in combination with 25 μM cisplatin, assessed as reduction in cell viability using CellTiter 96 AQueous One Solution assay with 16 h pre-incubation of planispine A.
Antiproliferative activity against human HeLa cancer cells in combination with 25 μM cisplatin, assessed as reduction in cell viability using CellTiter 96 AQueous One Solution assay with 16 h pre-incubation of planispine A.
|
36364114 |
体外実験
Planispine A (5-10 μM; 16 h) inhibits the Fanconi anemia pathway in HeLa cells by reducing cisplatin-induced FANCD2 foci formation and monoubiquitination modification, with monoubiquitination completely blocked at a concentration of 10 μM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
化学情報
-
CAS 番号 1202761-42-9
-
分子量 426.50
-
分子式 C25H30O6
-
SMILES
COC1=C(OC/C=C(C)/C)C=CC([C@H]2[C@@]3([H])[C@](CO2)([H])[C@@H](C4=CC(OC)=C(C=C4)O)OC3)=C1
-
Structure Classification
-
Initial Source
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)